Rebiotix has a total of 142 patents globally, out of which 83 have been granted. Of these 142 patents, more than 78% patents are active. The United States of America is where Rebiotix has filed the maximum number of patents, followed by Australia and Europe (EPO). Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Rebiotix.
Rebiotix was founded in 2011. Rebiotix is a development-stage biotechnology company focusing on the treatment of GI diseases by developing human microbiome.
Do read about some of the most popular patents of Rebiotix which have been covered by us in this article and also you can find Rebiotix patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Rebiotix patent portfolio.
How many patents does Rebiotix have?
Rebiotix has a total of 142 patents globally. These patents belong to 18 unique patent families. Out of 142 patents, 112 patents are active.
How Many Patents did Rebiotix File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Rebiotix Applications Filed | Rebiotix Patents Granted |
2023 | 1 | 5 |
2022 | 5 | 16 |
2021 | 4 | 11 |
2020 | 10 | 13 |
2019 | 9 | 14 |
2018 | 16 | 9 |
2017 | 25 | 8 |
2016 | 22 | 5 |
2015 | 5 | 2 |
2014 | 26 | – |
How many Rebiotix patents are Alive/Dead?
Worldwide Patents
How Many Patents did Rebiotix File in Different Countries?
Countries in which Rebiotix Filed Patents
Country | Patent |
United States of America | 40 |
Australia | 15 |
Europe (EPO) | 12 |
Korea (South) | 9 |
Hong Kong (S.A.R.) | 8 |
Canada | 7 |
China | 6 |
Spain | 5 |
Israel | 5 |
Japan | 4 |
Russian Federation | 3 |
Poland | 3 |
Hungary | 2 |
Brazil | 2 |
Denmark | 2 |
Croatia | 2 |
Slovenia | 2 |
Lithuania | 2 |
Turkey | 2 |
Mexico | 2 |
Portugal | 2 |
India | 1 |
Serbia | 1 |
Where are Research Centers of Rebiotix Patents Located?
The Research Centers of Rebiotix Patents is the United States of America.
10 Best Rebiotix Patents
US9433651B2 is the most popular patent in the Rebiotix portfolio. It has received 69 citations so far from companies like uBiome, Psomagen, Prolacta Bioscience.
Below is the list of 10 most cited patents of Rebiotix:
Publication Number | Citation Count |
US9433651B2 | 69 |
WO2014197562A1 | 38 |
WO2016201114A1 | 14 |
US9675648B2 | 11 |
US20140363400A1 | 11 |
US10226431B2 | 9 |
US9629881B2 | 7 |
CN107921072A | 7 |
US10828340B2 | 6 |
US9511099B2 | 6 |
What Percentage of Rebiotix US Patent Applications Were Granted?
Rebiotix (Excluding its subsidiaries) has filed 12 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 10 have been granted leading to a grant rate of 83.33%.
Below are the key stats of Rebiotix patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Rebiotix?
Law Firm | Total Applications | Success Rate |
Foley & Lardner Llp | 11 | 90.91% |
Seager Tufte & Wickhem Llp | 1 | 0% |
What are Rebiotix key innovation segments?
What Technologies are Covered by Rebiotix?
The chart below distributes patents filed by Rebiotix